Research got us here.

Capital gets us there.

Of the 1,000+ early-stage companies in our pipeline, we’ve invested in 9 — across diagnostics, therapeutics, and other innovations targeting cancer. Many of them targeting the cancers that have touched your family — or someone you love. For most of these companies, the critical problem isn’t science. It’s capital.

HOW WOULD YOU LIKE TO PARTICIPATE?

I want to GIVE to support cancer innovation

Donate by credit or debit card or donor-advised fund (DAF) grant; open to everyone

I want to INVEST to support cancer innovation

Verified accredited investors only; see subscription documents for current minimum and terms

I want to JOIN THE COMMUNITY to follow the future of cancer care

Free to join and follow the innovations moving beyond the lab to patients

I represent a FAMILY OFFICE, FOUNDATION, or INSTITUTIONAL investor

Explore investment and partnership opportunities

12

INVESTMENTS MADE

9

SUPPORTED COMPANIES

10,000+

COMMUNITY MEMBERS

$10B+

EARLY-STAGE FUNDING GAP

TWO PATHS, ONE MISSION

Whether you give or invest,

you can help advance the mission.

Choose the path that BEST fits your goals.

VENTURE GIVING

CANCER FUND Community Donor Advised Fund (CFC-DAF) at ImpactAssets

Now, anyone touched by cancer can join in supporting cancer innovation:

Donate $10 or more by credit or debit card, plus 3.5% card processing fees
Grant $250 or more from your own DAF; minimums, fees, and other details vary by granting DAF provider
Setup your own DAF in only a few minutes
Donating, making a grant recommendation, or setting up a DAF takes only 2–3 minutes; we’ll help guide you through it
Charitable grants administered by ImpactAssets (501(c)(3)); not a securities transaction

VENTURE CAPITAL

Cancer Fund I, LLC from CANCER FUND Impact Investments ®

Early-stage oncology venture capital. For verified accredited investors; see subscription documents for current minimum and terms.

Supporting pre-clinical and early-clinical innovations
Primarily Seed through Series A,
See subscription documents for current minimum and terms
12 investments in 9 companies as of April 30, 2026
10-year fund term

LEARN MORE ABOUT GIVING

LEARN MORE ABOUT INVESTING

WHY CANCER FUND?

Three reasons.

THE FUNDING GAP IS REAL AND QUANTIFIABLE 1,000+ early-stage oncology companies are seeking $10B+ in capital — with 95% of that need at Seed and Series A, where traditional VC has stopped showing up.

YOUR CAPITAL MAKES A BIG DIFFERENCE

Patient capital at the earliest stage funds the proof points that unlock everything that comes after.

YOU DON’T HAVE TO DO IT ALONE

Whether you give or invest, you’re joining a 10,000+ community of physicians, scientists, survivors, and others who back this work together.

MORE: WHY CANCER FUND?

Want to get more deeply involved?

Beyond the community, our Screening Committee is a smaller group of members who help evaluate the companies we fund. It’s selective and invitation-based — but if your background fits, we’d love to know you’re interested.

TELL US MORE ABOUT YOU

PORTFOLIO

9 Companies. 12 Investments

One Focus: Patient Outcomes

GLIOBLASTOMA

Reglagene

Therapeutics

SERIES A

BREAST CANCER

NearWave

Diagnostics & Monitoring

SEED

OVARIAN CANCER

AOA Dx

Diagnostics & Monitoring

SERIES A-1

MULTI-CANCER

Avesta76

Therapeutics

SEED

LEUKEMIA / LYMPHOMA

March Biosciences

Therapeutics

SERIES A

BLADDER CANCER

Cellens

Diagnostics

SERIES SEED-1

HER2 BREAST CANCER

Veana

Therapeutics

SEED 2A

PAN-CANCER

NxGenPort

Remote Monitoring

SEED

PANCREATIC CANCER

ANNOUNCING SOON

OUR COMMUNITY

10,000+

STAKEHOLDER COMMUNITY MEMBERS

PHYSICIANS & ONCOLOGISTS

RESEARCHERS & SCIENTISTS

SURVIVORS & CAREGIVERS

IMPACT INVESTORS

INDUSTRY PROFESSIONALS

Built over five years, our community follows the work — receiving updates on companies we back, milestones they hit, and patients they reach. There’s no commitment required to join; just a shared interest in seeing cancer innovation reach patients faster.

JOIN OUR COMMUNITY

INSTITUTIONAL PARTNERS

For family offices, foundations, and institutions

The CANCER FUND team and community of 10,000+ physicians, researchers, industry experts, and survivors may collaborate to help achieve our mutual oncology investment objectives.

The right structure depends on your objectives and shared interests — let’s start with a conversation.

GET IN TOUCH

GET INVOLVED

Three ways to help advance

cancer innovation

Whether you’re a mission-aligned donor or an accredited investor, there’s a path for you.

For Donors

Donate to the community DAF

Charitable giving via ImpactAssets. Open to anyone. No accreditation required.

DONATE

For DAF Holders

Recommend a grant from a DAF

Recommend a grant from your existing DAF to ImpactAssets. No accreditation required.

RECOMMEND A GRANT

For Investors

Invest in Cancer Fund I

Early-stage oncology venture capital. For verified accredited investors; see subscription documents for current minimum and terms.

START INVESTING